Light ‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome
ConclusionBoth TTR ‐ and AL‐CA can accompany severe AS. Parameters solely based on ECG and echocardiography allow for the identification of the majority of CA‐AS. In the present cohort, CA did not significantly worsen prognosis 15.3 months after TAVR.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Christian Nitsche,
Stefan Aschauer,
Andreas A. Kammerlander,
Matthias Schneider,
Thomas Poschner,
Franz Duca,
Christina Binder,
Matthias Koschutnik,
Julian Stiftinger,
Georg Goliasch,
Jolanta Siller ‐Matula,
Max‐Paul Winter,
Anahit Anvari Tags: Research Article Source Type: research
More News: Amyloidosis | Aortic Stenosis | Cardiology | Electrocardiogram | Heart | Heart Failure | Heart Valve Surgery | MRI Scan | Stroke